Survival, mortality, and complications in patients with β-thalassemia major in northern Taiwan

被引:39
作者
Chern, Jimmy P. S.
Su, Syi
Lin, Kai-Hsin
Chang, Shu-Hui
Lu, Meng-Yao
Jou, Shiann-Tarng
Lin, Dong-Tsamn
Ho, Wan-Ling
Lin, Kuo-Sin
机构
[1] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei 10016, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Care Org Adm, Taipei 10764, Taiwan
[5] Tao Yuan Gen Hosp, Dept Family Med, Dept Hlth, Tao Yuan, Taiwan
关键词
beta-thalassemia major; causes of death; iron-chelation therapy; survival;
D O I
10.1002/pbc.21028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Advances in treatment have improved the prognosis in beta-thalassemia major. We present the survival and complications pattern of those patients in northern Taiwan born after 1970. Procedure. One-hundred and sixty patients with beta-thalassemia major born after 1970 were collected. The Kaplan-Meier method and log-rank test were used to estimate and compare survival. Cox regression models were used to examine the associations of bone marrow transplantation (BMT), time of BMT procedure, and time of complications with survival. Results. Better survival was observed for patients born after 1980 (P=0.0121). Heart disease, BMT-related deaths, and infections were the main causes of death. Among the living patients over age 15, hypogonadotropic hypogonadism, HCV infection, diabetes, heart failure, and arrhythmia were the common complications. No patients under age 15 had complications. Conclusions. Survival for patients with beta-thalassemia major has improved significantly in Taiwan. More time is required to demonstrate whether these modalities added to the treatment of these patients will impact favorably on their outcome. Our success with BMT is improving and we are now in a position to offer this curative alternative.
引用
收藏
页码:550 / 554
页数:5
相关论文
共 20 条
[1]   Survival and complications in thalassemia [J].
Borgna-Pignatti, C ;
Cappellini, MD ;
De Stefano, P ;
Del Vecchio, GC ;
Forni, GL ;
Gamberini, MR ;
Ghilardi, R ;
Origa, R ;
Piga, A ;
Romeo, MA ;
Zhao, H ;
Cnaan, A .
COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 :40-47
[2]  
Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187
[3]   EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOAD IN PATIENTS WITH THALASSEMIA MAJOR [J].
BRITTENHAM, GM ;
GRIFFITH, PM ;
NIENHUIS, AW ;
MCLAREN, CE ;
YOUNG, NS ;
TUCKER, EE ;
ALLEN, CJ ;
FARRELL, DE ;
HARRIS, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09) :567-573
[4]   Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia [J].
Chern, JPS ;
Lin, KH ;
Tsai, WY ;
Wang, SC ;
Lu, MY ;
Lin, DT ;
Lin, KS ;
Lo, SH .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (11) :880-884
[5]   Abnormal glucose tolerance in transfusion-dependent β-thalassemic patients [J].
Chern, JPS ;
Lin, KH ;
Lu, MY ;
Lin, DT ;
Lin, KS ;
Chen, JD ;
Fu, CC .
DIABETES CARE, 2001, 24 (05) :850-854
[6]   Klebsiella infection in patients with Thalassemia [J].
Chung, BHY ;
Ha, SY ;
Chan, GCF ;
Chiang, A ;
Lee, TL ;
Ho, HK ;
Lee, CY ;
Luk, CW ;
Lau, YL .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :575-579
[7]   Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with β-thalassemia major [J].
Jaing, TH ;
Hung, IJ ;
Yang, CP ;
Chen, SH ;
Sun, CF ;
Chow, R .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (05) :349-353
[8]  
KO T-M, 1989, Taiwan yixuehui zazhi, V88, P678
[9]   Age as a factor in severe bacterial infection in transfusion-dependent patients with thalassemia major [J].
Lee, ACW ;
Li, CH .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (08) :1194-1195
[10]  
Lin Kai-Hsin, 1992, Journal of the Formosan Medical Association, V91, P126